Previous Video
BIO-Europe Spring® 2016: Synthetic Biologics CEO outlines development plans for lead assets
BIO-Europe Spring® 2016: Synthetic Biologics CEO outlines development plans for lead assets

Synthetic Biologics CEO Jeffrey Riley outlines to Pharma Intelligence Senior Editor Sten Stovall how the cl...

Next Video
Maximizing Your Success and Networking Objectives at the BIO-Europe Spring® Conference in Stockholm
Maximizing Your Success and Networking Objectives at the BIO-Europe Spring® Conference in Stockholm

On April 4–6, approximately 2,000+ executives and investors from the biotechnology and pharmaceutical indus...